If approved, Scemblix will be indicated for adults with chronic myeloid leukemia (CML), both newly diagnosed and previously treated, expanding access to four times as many patients in EuropeScemblix ...

Partnership celebrates the Blue Jackets’ 25th season and their longstanding commitment to literacy, education, and community ...

Phyrago is a novel formulation of Sprycel ® (dasatinib) designed to enable concomitant use with proton pump inhibitors (PPIs) and H 2 receptor antagonists (H 2 RAs). 1 Clinical data showed no ...

Results show maximum placebo-adjusted weight loss of 4.6% with 12% treatment discontinuation due to adverse events Asymptomatic, reversible grade 3 liver enzyme elevations occurred in three ...

Various symptoms indicate chronic myelogenous leukemia (CML) has progressed from one phase to another. These include an increase in leukemia cells, a change in a person’s platelet count, and worsening ...

The FDA has issued a complete response letter (CRL) to a new drug application (NDA) for Dasynoc for the treatment of chronic ...

Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer. It starts in blood-forming cells within the bone marrow, creating leukemia cells. These cells transfer ...

A Charlotte-based library services company will close its doors next year. Baker & Taylor will shutter its headquarters off ...